The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
Secretory Leukocyte Protease Inhibitor (SLPI) is a serine protease inhibitor produced by epithelial and myeloid cells with anti-inflammatory properties. Research has shown that SLPI exerts its anti-inflammatory activity by directly binding to NF-κB DNA binding sites and, in so doing, prevents bindin...
Saved in:
Main Authors: | Niamh McGarry, Catherine M. Greene, Noel G. McElvaney, Sinéad Weldon, Clifford C. Taggart |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/507315 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung
by: Matthew S. Twigg, et al.
Published: (2015-01-01) -
Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa
by: Max Nyström, et al.
Published: (2001-01-01) -
Secretory Leukocyte Protease Inhibitor Is an Inducible Antimicrobial Peptide Expressed in Staphylococcus aureus Endophthalmitis
by: Victor E. Reviglio, et al.
Published: (2007-01-01) -
Effects of Pregnancy and Bacterial Vaginosis on Proinflammatory Cytokine and Secretory Leukocyte Protease Inhibitor Concentrations in Vaginal Secretions
by: Jennifer Balkus, et al.
Published: (2010-01-01) -
IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release
by: U. Westin, et al.
Published: (1998-01-01)